UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): X Form 10-K __ Form 20-F X Form 10-Q __ Form N-SAR
For period ended: September 30, 1997
[ ] Transition Report on Form 10-K and Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q and Form 10-QSB
[ ] Transition Report on Form N-SAR
For the transition period ended
SEC File Number 0-11472
CUSIP Number - 09061T509
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:________________________________
PART I-REGISTRANT INFORMATION
BIOMUNE SYSTEMS, INC.
- --------------------------------------
Full Name of Registrant
2401 South Foothill Dr.
Salt Lake City, Utah 84109
(801) 466-3441
- --------------------------------------
Address and telephone number of
principal executive office
PART II-RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check appropriate box)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or portion thereof
will be filed on or before the 15th calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q, 10-QSB, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III-NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 10-KSB,
11-K, 20-F 10-Q, 10-QSB, N-SAR or the transition report portion thereof,
could not be filed within the prescribed time period.
The annual report of the registrant on Form 10-K could not be filed because of
delays encountered in finalizing the financial and other information needed to
complete the report as it relates to the effects of the divestiture of the
Company's subsidiary corporation, Volu-Sol, Inc., the on-going efforts to
finalize the terms of the Rockwood Cosmetics, Inc. acquisition, and recent
personnel changes at the registrant.
PART IV-OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Michael G. Acton, CFO (801) 466-3441
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) or the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months (or for such shorter period that the
registrant was required to file such report(s)) been filed? If the answer is
no, identify report(s). X Yes __ No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
__ Yes X No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
BIOMUNE SYSTEMS, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date December 29, 1997 By: /s/ Michael G. Acton
---------------------------------
Michael G. Acton, Chief Financial Officer
